Amoxapine



Amoxapine





(a mox’ a peen)

PREGNANCY CATEGORY C


Drug Classes

Anxiolytic

TCA


Therapeutic Actions

Mechanism of action unknown; TCAs inhibit the reuptake of the neurotransmitters norepinephrine and serotonin, leading to an increase in their effects; anticholinergic at CNS and peripheral receptors; sedative.


Indications



  • Relief of symptoms of depression in patients with neurotic or reactive depressive disorders and in those with endogenous and psychotic depression (endogenous depression most responsive)


  • Treatment of depression accompanied with anxiety or agitation



Available Forms

Tablets—25, 50, 100, 150 mg


Dosages

Adults

Initially, 50 mg PO bid–tid; gradually increase to 100 mg bid–tid by end of first wk if tolerated; increase above 300 mg/day only if this dosage ineffective for at least 2 wk. Hospitalized patients refractory to antidepressant therapy and with no history of seizures may be given up to 600 mg/day in divided doses; after effective dosage is established, drug may be given in a single dose at bedtime (maximum, 300 mg). Usual effective dose is 200–300 mg/day.

Pediatric patients

Not recommended for patients younger than 16 yr.

Geriatric patients

Initially, 25 mg bid–tid; if tolerated, dosage may be increased by end of first week to 50 mg bid–tid. For many elderly patients, 100–150 mg/day may be adequate; some may require up to 300 mg/day. Once effective dose is established, give as single dose at bedtime, not to exceed 300 mg.


Pharmacokinetics

















Route Onset Peak Duration
Oral Varies 90 min 2–4 wk

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in NURSING | Comments Off on Amoxapine

Full access? Get Clinical Tree

Get Clinical Tree app for offline access